Related references
Note: Only part of the references are listed.Inhibitory effect of IQ-1S, a selective c-Jun N-terminal kinase (JNK) inhibitor, on phenotypical and cytokine-producing characteristics in human macrophages and T-cells
Victor Seledtsov et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2020)
The neuroprotective effects of an ethanolic turmeric (Curcuma longa L.) extract against trimethyltin-induced oxidative stress in rats
Sapto Yuliani et al.
NUTRITIONAL NEUROSCIENCE (2019)
Protective Effects of a New C-Jun N-terminal Kinase Inhibitor in the Model of Global Cerebral Ischemia in Rats
Mark B. Plotnikov et al.
MOLECULES (2019)
The impact of sex and age on T cell immunity and ischemic stroke outcomes
Hilda Ahnstedt et al.
CELLULAR IMMUNOLOGY (2019)
The Involvement and Therapy Target of Immune Cells After Ischemic Stroke
Zhihong Jian et al.
FRONTIERS IN IMMUNOLOGY (2019)
Synthesis, biological evaluation, and molecular modeling of 11H-indeno[1,2-b]quinoxalin-11-one derivatives and tryptanthrin-6-oxime as c-Jun N-terminal kinase inhibitors
Igor A. Schepetkin et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
c-Jun N-Terminal Kinases (JNKs) in Myocardial and Cerebral Ischemia/Reperfusion Injury
Maria Shvedova et al.
FRONTIERS IN PHARMACOLOGY (2018)
A novel dual NO-donating oxime and c-Jun N-terminal kinase inhibitor protects against cerebral ischemia-reperfusion injury in mice
Dmitriy N. Atochin et al.
NEUROSCIENCE LETTERS (2016)
Luoyutong Treatment Promotes Functional Recovery and Neuronal Plasticity after Cerebral Ischemia-Reperfusion Injury in Rats
Ning-qun Wang et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2015)
The role of the nitric oxide pathway in brain injury and its treatment - From bench to bedside
P. S. Garry et al.
EXPERIMENTAL NEUROLOGY (2015)
c-Jun N-terminal kinase inhibitors: a patent review (2010-2014)
Matthias Gehringer et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2015)
Inhibitors of c-Jun N-Terminal Kinases: An Update
Pierre Koch et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Anti-Inflammatory Effects and Joint Protection in Collagen-Induced Arthritis after Treatment with IQ-1S, a Selective c-Jun N-Terminal Kinase Inhibitor
Igor A. Schepetkin et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2015)
The protective effect of HET0016 on brain edema and blood-brain barrier dysfunction after cerebral ischemia/reperfusion
Yu Liu et al.
BRAIN RESEARCH (2014)
Aminopurine based JNK inhibitors for the prevention of ischemia reperfusion injury
Veronique Plantevin Krenitsky et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
S-Nitrosylation of Mixed Lineage Kinase 3 Contributes to Its Activation after Cerebral Ischemia
Shu-Qun Hu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Delayed Inhibition of c-Jun N-Terminal Kinase Worsens Outcomes after Focal Cerebral Ischemia
Yoshihiro Murata et al.
JOURNAL OF NEUROSCIENCE (2012)
Identification and Characterization of a Novel Class of c-Jun N-terminal Kinase Inhibitors
Igor A. Schepetkin et al.
MOLECULAR PHARMACOLOGY (2012)
Microcirculation and blood rheology in patients with cerebrovascular disorders
Irina A. Tikhomirova et al.
CLINICAL HEMORHEOLOGY AND MICROCIRCULATION (2011)
Update of the Stroke Therapy Academic Industry Roundtable Preclinical Recommendations
Marc Fisher et al.
STROKE (2009)
AS601245, a c-Jun NH2-terminal kinase (JNK) inhibitor, reduces axon/dendrite damage and cognitive deficits after global cerebral ischaemia in gerbils
S. Carboni et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Exogenous nitric oxide negatively regulates c-Jun N-terminal kinase activation via inhibiting endogenous NO-induced S-nitrosylation during cerebral ischemia and reperfusion in rat hippocampus
Dong-Sheng Pei et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Coupling between neuronal nitric oxide synthase and glutamate receptor 6-mediated c-Jun N-terminal kinase signaling pathway via S-nitrosylation contributes to ischemia neuronal death
H. -M. Yu et al.
NEUROSCIENCE (2008)
Vasorelaxant activity of some oxime derivatives
Filip Jaros et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2007)
Life after cerovive - A personal perspective on ischemic neuroprotection in the post-NXY-059 era
Myron D. Ginsberg
STROKE (2007)
Molecular targets in cerebral ischemia for developing novel therapeutics
Suresh L. Mehta et al.
BRAIN RESEARCH REVIEWS (2007)
Therapeutic strategies for the treatment of stroke
A. Richard Green et al.
DRUG DISCOVERY TODAY (2006)
Neuroprotection against ischemic brain injury by SP600125 via suppressing the extrinsic and intrinsic pathways of apoptosis
Qiu-Hua Guan et al.
BRAIN RESEARCH (2006)
Toward a multimodal neuroprotective treatment of stroke
A Rogalewski et al.
STROKE (2006)
Activation of c-Jun NH2-terminal kinase 3 is mediated by the GluR6•PSD-95•MLK3 signaling module following cerebral ischemia in rat hippocampus
H Tian et al.
BRAIN RESEARCH (2005)
Antioxidant strategies in the treatment of stroke
I Margaill et al.
FREE RADICAL BIOLOGY AND MEDICINE (2005)
Neuroprotection against focal ischemic brain injury by inhibition of c-Jun N-terminal kinase and attenuation of the mitochondrial apoptosis-signaling pathway
YQ Gao et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2005)
Targeting the JNK Signaling Pathway for Stroke and Parkinson's Diseases Therapy
Chia-Yi Kuan et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2005)
Free Radical Trapping as a Therapeutic Approach to Neuroprotection in Stroke: Experimental and Clinical Studies with NXY-059 and Free Radical Scavengers
A. Richard Green et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2005)
Specific pathophysiological functions of JNK isoforms in the brain
S Brecht et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2005)
The neuroprotective effects of K252a through inhibiting MLK3/MKK7/JNK3 signaling pathway on ischemic brain injury in rat hippocampal CA1 region
J Pan et al.
NEUROSCIENCE (2005)
AS601245 (1,3-benzothiazol-2-yl(2-{[2-(3-pyridinyl)ethyl]amino}-4 pyrimidinyl) acetonitrile):: A c-Jun NH2-terminal protein kinase inhibitor with neuroprotective properties
S Carboni et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
A peptide inhibitor of c-Jun N-terminal kinase protects against excitotoxicity and cerebral ischemia
T Borsello et al.
NATURE MEDICINE (2003)
Early modifications in the expression of mitogen-activated protein kinase (MAPK/ERK), stress-activated kinases SAPK/JNK and p38, and their phosphorylated substrates following focal cerebral ischemia
I Ferrer et al.
ACTA NEUROPATHOLOGICA (2003)
Role of mitogen- and stress-activated kinases in ischemic injury
EA Irving et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2002)
Signal transduction by the JNK group of MAP kinases
RJ Davis
CELL (2000)
Alteration of MAP kinase pathways after transient forebrain ischemia
BR Hu et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2000)
c-Jun N-terminal kinase (JNK) and JNK interacting protein response in rat brain after transient middle cerebral artery occlusion
T Hayashi et al.
NEUROSCIENCE LETTERS (2000)